Sign in to view content

Continuous submicrogram fluocinolone acetonide (FAc) therapy for the treatment of diabetic retinopathy

Charles C Wykoff, MD, PhD, FASRS

Video
Published 2017

Related

Dual Targeting VEGF/Ang3 Surrobody in an Experimental Model of Neovascularization
Jeffrey L. Olson, MD
Annual Meeting Talks
2019
Ultra-Widefield OCTA for Evaluation of Diabetic Retinopathy
Kasra Rezaei, M.D.
Updates from the Field
2017
Baseline DR Severity and Time to DME Resolution in Patients Treated With Ranibizumab in the RIDE and RISE Clinical Trials
Katherine E Talcott, MD
Annual Meeting Talks
2021

Category: Diabetic Retinopathy

See more